Who owns Harmony Biosciences Holdings, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HRMY from SEC Form 13F filings across 359 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 359 institutions disclosed 56.8M shares of Harmony Biosciences Holdings, Inc. worth $2.23B — about 97.2% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
359
13F holders
$2.23B
value, 2026 filers
97.2%
of shares outstanding (56.8M sh)
68
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of HRMY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.9M | $311.3M | 0.0% | 13.6% | +11.6% |
| 2 | FMR LLC | 3.3M | $128.3M | 0.0% | 5.6% | -8.5% |
| 3 | AMERICAN CENTURY COMPANIES INC | 3.1M | $122.2M | 0.1% | 5.3% | +22.6% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.0M | $116.6M | 0.0% | 5.1% | +3.1% |
| 5 | DIMENSIONAL FUND ADVISORS LP | 2.6M | $104.0M | 0.0% | 4.5% | +10.7% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $86.7M | 0.0% | 3.8% | +4.9% |
| 7 | LSV ASSET MANAGEMENT | 2.2M | $86.6M | 0.2% | 3.8% | +7.0% |
| 8 | STATE STREET CORP | 2.1M | $83.6M | 0.0% | 3.6% | +14.6% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $60.8M | 0.0% | 2.7% | +7.4% |
| 10 | ARMISTICE CAPITAL, LLC | 1.4M | $56.4M | 0.7% | 2.5% | -8.2% |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 1.4M | $54.9M | 0.1% | 2.4% | +16.9% |
| 12 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.3M | $49.7M | 0.0% | 2.2% | -3.5% |
| 13 | TWO SIGMA INVESTMENTS, LP | 1.1M | $44.5M | 0.0% | 1.9% | +18.2% |
| 14 | Allspring Global Investments Holdings, LLC | 1.1M | $44.5M | 0.1% | 1.9% | +548.5% |
| 15 | AQR CAPITAL MANAGEMENT LLC | 1.0M | $40.2M | 0.0% | 1.8% | +9.6% |
| 16 | MORGAN STANLEY | 785,962 | $30.9M | 0.0% | 1.3% | +7.1% |
| 17 | Invesco Ltd. | 699,607 | $27.5M | 0.0% | 1.2% | +32.4% |
| 18 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 597,700 | $23.5M | 0.0% | 1% | +8.5% |
| 19 | GOLDMAN SACHS GROUP INC | 588,397 | $23.1M | 0.0% | 1% | +45.8% |
| 20 | UBS Group AG | 538,504 | $21.1M | 0.0% | 0.9% | -10.7% |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 528,786 | $20.8M | 0.0% | 0.9% | +24.8% |
| 22 | NORTHERN TRUST CORP | 493,623 | $19.4M | 0.0% | 0.8% | +4.8% |
| 23 | NOMURA HOLDINGS INC | 471,349 | $18.5M | 0.0% | 0.8% | +12.8% |
| 24 | Boston Partners | 423,647 | $16.6M | 0.0% | 0.7% | +1289.9% |
| 25 | VICTORY CAPITAL MANAGEMENT INC | 419,105 | $16.5M | 0.0% | 0.7% | +5.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.